DSC_6781
Saturday, February 21, 2026
18.4
C
Bengaluru
Hot topics
Don’t Do Digital for the Sake of Doing Digital
Catalyzed by the pandemic, the pharma industry quickly progressed from being digitally agnostic to a state of preparedness.
The shift required the industry to experiment with technology in its customer-facing plans, which resulted in many cases the creation of random acts of digital, often without a cohesive overarching strategy.
Can pharma do better? The answer lies in understanding the utility of their digital assets while building a mindset to transform, and ensuring that teams within the organization do not work at cross-purposes.
Customer Acquisition Cost (CAC) & Indian Pharma
Introduction
Customer Acquisition Cost (CAC) is a key metric representing...
IPM November 2025 Sales Data Analysis
IPM Momentum, Innovation Waves & the AQI-Driven Respiratory Surge...
When Influence Meets Accountability: Why India Wants Wellness Gurus to Show Their Credentials
India’s wellness economy is booming—nutraceuticals, supplements, and alternative therapies...
Alok Sonig Appointed CEO of Rosemont Pharmaceuticals
Effective January 1, 2026, Rosemont Pharmaceuticals has announced the...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
Hot topics
If Strategy is Commodity, How Can Organisations Ensure Differentiation?
Strategy and strategic planning are perhaps the most hyped-up...
GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug
In a bold move to strengthen its hepatology pipeline,...
Indian Pharma – The Emerging Role of Hybrid Sales Model
COVID-19 has accelerated the shift in how pharma was engaging with HCPs, professional organisations and even patients in India from a sales to more of a scientific, unbiased and balanced marketing communications. As one of the business leader from a prominent MNC said, “For the first time we are seeing a certain shift in HCP’s preference for scientific communication for innovators companies. MSLs and scientific operation teams will be playing a key role in the near future.”
DiME (Digi MarketEr):-TiME to SHiNE
The new sparkling DIME (Digi MarketEr) are the ones who embrace digital transformation with open arms and voraciously feed on data analytics to satisfy their performance outcomes with an informed business decision. The benefit of being DIME is that it propels data management out of the hands of individual stakeholders, and puts data sets with insights on to center glass table (Transparent workplace) for informed decision making.
Time for Pharma to Re-think its Way of Working
https://www.youtube.com/watch?v=BOO_CNxEzwQ
Too many Medical Reps are chasing too few doctors,...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
Newsletter
Get important news delivered directly to your inbox and stay connected!